Washington, D.C. — Neil Bradley, Executive Vice President and Chief Policy Officer, U.S. Chamber of Commerce issued the following statement today supporting the call for a report on the security of the U.S. medical product supply chain:
“The Chamber applauds Leader McConnell and other authors of the Coronavirus Aid, Relief, and Economic Security Act for including a mandate for the National Academies to issue a report on the security of the U.S. medical product supply chain. As proposals circulate to impose new domestic production mandates on manufacturers of medicines and medical equipment in the midst of the present national emergency, a closer examination of the issues is clearly needed.
“We have insufficient stockpiles of medical countermeasures and other critical products, but we must avoid domestic production mandates that could inadvertently reduce supplies of critical products in the short term. While the administration is working closely with industry to address immediate needs, we need a firmer analysis before proceeding with the reported domestic production executive order that could be counterproductive. Further, such moves could deprive vibrant U.S. companies of access to international markets and inputs in a way that could undermine economic recovery.”
